FindTrial
Sign In

Population pharmacokinetics of amisulpride

Population pharmacokinetics of amisulpride

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061178
Enrollment
Unknown
Registered
2022-06-15
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

None listed

Sponsors

Beijing Anding Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 90 Years

Inclusion criteria

Inclusion criteria: All inpatients using amisulpride from 2018 to February 2020 in Beijing Anding Hospital

Exclusion criteria

Exclusion criteria: No drug concentration test data

Design outcomes

Primary

MeasureTime frame
Drug concentration of amisulpride;—

Countries

China

Contacts

Public ContactAnning Li

Beijing Anding Hospital Affiliated to Capital Medical University

anning.li@hotmail.com+86 13141209427

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026